<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>5(1)</volume><submitter>Dean C</submitter><funding>bBraun</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>Venous thromboembolism (VTE) is a frequent condition worldwide, associated with significant morbidity and mortality. Though its primary treatment is anticoagulation, the placement of an inferior vena cava (IVC) filter is recommended in patients with some comorbidities. The objectives of this study were to evaluate the clinical safety and efficacy of the Venatech® retrievable IVC filter. This open-label prospective single-center study was conducted on 40 consecutive patients requiring temporary or permanent IVC filtration. Patient characteristics, technical success rates of filter placement and removal, and the occurrence of complications were assessed. Follow-up imaging was performed using CT-scan before retrieval or at 6 months in the permanent indication population.&lt;h4</pubmed_abstract><journal>CVIR endovascular</journal><pagination>50</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9532491</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Safety and efficacy of the VenaTech™ Retrievable inferior vena cava filter: a first-in-man single-center prospective study.</pubmed_title><pmcid>PMC9532491</pmcid><pubmed_authors>Sanchez O</pubmed_authors><pubmed_authors>Pellerin O</pubmed_authors><pubmed_authors>Martelli N</pubmed_authors><pubmed_authors>Sapoval M</pubmed_authors><pubmed_authors>Kim YI</pubmed_authors><pubmed_authors>Dean C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Safety and efficacy of the VenaTech™ Retrievable inferior vena cava filter: a first-in-man single-center prospective study.</name><description>&lt;h4>Background&lt;/h4>Venous thromboembolism (VTE) is a frequent condition worldwide, associated with significant morbidity and mortality. Though its primary treatment is anticoagulation, the placement of an inferior vena cava (IVC) filter is recommended in patients with some comorbidities. The objectives of this study were to evaluate the clinical safety and efficacy of the Venatech® retrievable IVC filter. This open-label prospective single-center study was conducted on 40 consecutive patients requiring temporary or permanent IVC filtration. Patient characteristics, technical success rates of filter placement and removal, and the occurrence of complications were assessed. Follow-up imaging was performed using CT-scan before retrieval or at 6 months in the permanent indication population.&lt;h4</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Oct</publication><modification>2025-04-22T21:52:26.112Z</modification><creation>2025-02-19T01:28:10.496Z</creation></dates><accession>S-EPMC9532491</accession><cross_references><pubmed>36194306</pubmed><doi>10.1186/s42155-022-00325-y</doi></cross_references></HashMap>